Engineered biomaterials for development of nucleic acid vaccines

Area of Science:

• Vaccinology
• Biomaterials Science
• Immunology

Background:

• Nucleic acid vaccines offer advantages over traditional vaccines but often show moderate immunogenicity.
• Vaccine route and formulation significantly impact immune response and overall efficacy.
• Biomaterials are crucial for enhancing antigen immunogenicity and facilitating cellular delivery.

Purpose of the Study:

• To review the evolution of biomaterials used in nucleic acid vaccine development.
• To discuss the advantages and disadvantages of various biomaterial structures for gene delivery and immunostimulation.
• To offer insights for rational carrier/adjuvant design and a deeper understanding of their mechanisms.

Main Methods:

• Literature review focusing on biomaterials for nucleic acid vaccines.
• Analysis of particle- and non-particle-mediated delivery pathways.
• Evaluation of biomaterials' roles in immunostimulation and antigen delivery.

Main Results:

• Biomaterials are essential for improving nucleic acid vaccine performance.
• Diverse biomaterial structures impact gene delivery and immune stimulation differently.
• A comprehensive understanding of biomaterial action is lacking.

Conclusions:

• Further research into biomaterial-based nucleic acid vaccines is needed.
• Rational design of carriers and adjuvants can enhance vaccine efficacy.
• Understanding delivery and immunostimulatory mechanisms is key for future vaccine development.